Novartis aims for 5% annual sales growth through 2027
Novartis said it was targeting annual sales growth of 5 per cent per year until 2027 and a core operating income margin of about 40 per cent by 2027, driven by innovative drugs on the market, after it severed ownership ties to its generic-drugs business.
![Novartis aims for 5% annual sales growth through 2027](https://cdn.zeebiz.com/sites/default/files/2023/11/28/270539-reuters-20.jpg?im=FitAndFill=(1200,900))
The Swiss company, which is updating investors on its research and development on Tuesday, reiterated it was aiming for a core operating income margin of at least 40 per cent by 2027, up from 35 per cent last year. Image Source: Reuters